Eli Lilly and Company

Associate Director-Project Manager, LAL@SH

Shanghai, Shanghai, China

$150,000 – $200,000Compensation
Senior (5 to 8 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant scientific field, such as Biology, Chemistry, or a related discipline, and have a minimum of 8 years of experience in project management, preferably within a pharmaceutical or biotechnology setting. Strong experience in leading complex automation projects, particularly in molecular biology, is essential. Demonstrated ability to manage cross-functional teams and collaborate effectively with stakeholders is required.

Responsibilities

The Associate Director/Project Manager will be responsible for developing and executing comprehensive project plans for molecular biology automation initiatives, including defining scope, objectives, and timelines. They will conduct feasibility studies, create work breakdown structures, and manage project schedules, allocating resources effectively. The role involves overseeing project execution, monitoring progress, identifying and addressing risks, and collaborating with internal and external stakeholders to ensure successful project delivery and the implementation of cutting-edge automation solutions.

Skills

Project Management
Molecular Biology
Automation
Cross-functional Teams
Stakeholder Management
Risk Management
Work Breakdown Structures
Resource Allocation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI